title: Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways.
abstract: OBJECTIVE
  Aldosterone (Aldo) antagonism prevents cardiovascular mortality by unclear mechanisms. Aldo binds to the mineralocorticoid receptor (MR), a ligand-activated transcription factor, which is expressed in human vascular cells. Here we define the early Aldo-regulated vascular transcriptome and investigate the mechanisms of gene regulation by Aldo in the vasculature that may contribute to vascular disease.
  
  
  RESULTS
  Gene expression profiling of Aldo-treated mouse aortas identified 72 genes regulated by Aldo. These genes are overrepresented in Gene Ontology categories involved in vascular function and disease. Quantitative reverse transcription-polymerase chain reaction was used to confirm and further explore mechanisms of vascular gene regulation by Aldo. Aldo-regulated vascular gene expression was inhibited by actinomycin D and MR antagonists supporting a transcriptional MR-dependent mechanism. Aldo regulation of a subset of genes was enhanced in the setting of vascular endothelial denudation and blocked by the free radical scavenger Tempol, supporting synergy between Aldo and vascular injury that is oxidative stress dependent. In the aortic arch, a region predisposed to atherosclerosis, the injury-enhanced genes also demonstrated enhanced expression compared with the descending aorta, both at baseline and after Aldo exposure. Furthermore, the clinically beneficial MR antagonist spironolactone inhibited expression of the identified genes in aortic tissue from humans with atherosclerosis.
  
  
  CONCLUSIONS
  This study defines the Aldo-regulated vascular transcriptome and characterizes a subset of proatherogenic genes with enhanced Aldo-stimulated, oxidative stress-dependent expression in the setting of vascular injury and in areas predisposed to atherosclerosis. Inhibition of MR regulation of these genes may play a role in the protective effects of Aldo antagonists in patients with vascular disease, and these pathways may provide novel drug targets to prevent atherosclerosis in humans.
authors: Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
authors: Brenna G
authors: BG
authors: Newfell
authors: Lakshmanan K
authors: LK
authors: Iyer
authors: Najwa N
authors: NN
authors: Mohammad
authors: Adam P
authors: AP
authors: McGraw
authors: Afshin
authors: A
authors: Ehsan
authors: Giuseppe
authors: G
authors: Rosano
authors: Paul L
authors: PL
authors: Huang
authors: Michael E
authors: ME
authors: Mendelsohn
authors: Iris Z
authors: IZ
authors: Jaffe
references: Ageing Res Rev. 2011 Jan;10(1):132-45
references: 20933613
references: N Engl J Med. 2003 Apr 3;348(14):1309-21
references: 12668699
references: Arterioscler Thromb Vasc Biol. 1997 Aug;17(8):1483-9
references: 9301624
references: J Am Soc Nephrol. 2008 Feb;19(2):298-309
references: 18184857
references: N Engl J Med. 1999 Sep 2;341(10):709-17
references: 10471456
references: Circulation. 2008 Dec 9;118(24):2515-22
references: 19029469
references: Circulation. 2004 May 11;109(18):2213-20
references: 15123520
references: BMC Bioinformatics. 2004 Feb 18;5:16
references: 14975175
references: Endocrinology. 2007 Apr;148(4):1502-10
references: 17234708
references: Endocrinology. 2006 Jul;147(7):3183-9
references: 16601137
references: Hypertension. 2009 Sep;54(3):537-43
references: 19635989
references: J Biol Chem. 2009 Mar 20;284(12):7665-72
references: 19141618
references: Mol Endocrinol. 2008 Nov;22(11):2544-56
references: 18787042
references: Circ Res. 2005 Apr 1;96(6):643-50
references: 15718497
references: J Mol Med (Berl). 2006 May;84(5):396-404
references: 16604333
references: N Engl J Med. 2007 Nov 22;357(21):2109-22
references: 17984165
references: Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2712-6
references: 11226305
references: Circ Res. 2008 Jun 6;102(11):1359-67
references: 18467630
references: Kidney Int. 2000 Apr;57(4):1352-7
references: 10760066
references: Steroids. 2000 Feb;65(2):61-73
references: 10639017
references: Nat Genet. 2006 Nov;38(11):1289-97
references: 17013392
references: Antioxid Redox Signal. 2009 Jul;11(7):1699-709
references: 19186981
references: Am J Physiol Heart Circ Physiol. 2002 Nov;283(5):H1802-10
references: 12384457
references: Endocrinology. 2003 Jun;144(6):2380-7
references: 12746298
references: Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):799-805
references: 17234727
references: Circulation. 2008 Dec 9;118(24):2506-14
references: 19029466
references: Cardiovasc Res. 1995 Jan;29(1):27-32
references: 7895235
references: Circulation. 2001 Jul 31;104(5):522-6
references: 11479247
references: Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):158-61
references: 19038849
references: Endocrinology. 2008 Mar;149(3):1009-14
references: 18079208
references: Cell Stress Chaperones. 2004 Autumn;9(3):243-52
references: 15544162
references: Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14871-6
references: 15466704
references: Hypertension. 2003 Jul;42(1):49-55
references: 12782645
references: Circ Res. 2001 Mar 30;88(6):615-22
references: 11282896
references: Am J Pathol. 2002 Nov;161(5):1773-81
references: 12414524
references: J Clin Invest. 2010 Nov;120(11):3891-900
references: 20921624
references: Hypertension. 2000 May;35(5):1099-104
references: 10818071
references: Ann Endocrinol (Paris). 2000 Feb;61(1):41-6
references: 10790591
references: FASEB J. 2006 Jul;20(9):1546-8
references: 16720735
references: Nature. 1995 Sep 21;377(6546):239-42
references: 7545787